Renin angiotensin blockers and cardiac protection: from basics to clinical trials

BI Lévy, JJ Mourad - American Journal of Hypertension, 2022 - academic.oup.com
Despite a similar beneficial effect on blood pressure lowering observed with angiotensin-
converting enzyme inhibitors (ACEIs) and angiotensin II type 1 receptor (AT1R) blocker …
被引用次数：23 相关文章

Renin Angiotensin Blockers and Cardiac Protection: From Basis to Clinical Trials.

BI Lévy, JJ Mourad - American Journal of Hypertension, 2022 - europepmc.org
Despite a similar beneficial effect on blood pressure lowering observed with angiotensin-
converting enzyme inhibitors (ACEIs) and angiotensin II type 1 receptor (AT1R) blocker …
[PDF] researchgate.net

[PDF][PDF] Renin Angiotensin Blockers and Cardiac Protection: From Basics to Clinical Trials

BI Lévy, JJ Mourad - American Journal of Hypertension, 2022 - researchgate.net
Despite a similar beneficial effect on blood pressure lowering observed with angiotensin-
converting enzyme inhibitors (ACEIs) and angiotensin II type 1 receptor (AT1R) blocker …

Renin Angiotensin Blockers and Cardiac Protection: From Basis to Clinical Trials

BI Lévy, JJ Mourad - American journal of hypertension, 2022 - pubmed.ncbi.nlm.nih.gov
Despite a similar beneficial effect on blood pressure lowering observed with angiotensin-
converting enzyme inhibitors (ACEIs) and angiotensin II type 1 receptor (AT1R) blocker …

Renin Angiotensin Blockers and Cardiac Protection: From Basics to Clinical Trials

BI Lévy, JJ Mourad - American Journal of Hypertension, 2022 - academic.oup.com
Despite a similar beneficial effect on blood pressure lowering observed with angiotensin-
converting enzyme inhibitors (ACEIs) and angiotensin II type 1 receptor (AT1R) blocker …

Renin Angiotensin Blockers and Cardiac Protection: From Basis to Clinical Trials.

BI Lévy, JJ Mourad - American Journal of Hypertension, 2022 - search.ebscohost.com
Despite a similar beneficial effect on blood pressure lowering observed with angiotensin-
converting enzyme inhibitors (ACEIs) and angiotensin II type 1 receptor (AT1R) blocker …